Opioid Disorder Use Research Study
Researchers at Virginia Commonwealth University are partnering with individuals to study the interaction between buprenorphine and an FDA-approved medication. Join our compensated study today!
Fast Facts
Currently in buprenorphine treatment for opioid use
Willing and able to complete the study which could be spread out over the course of up to 84 days
ages 18-65
Compensation Provided
Conducted in Richmond, VA
Study Background
Virginia Commonwealth University is looking for participants to study the interaction between buprenorphine and an FDA-approved medication.
Our study is to examine safety-tolerability and drug-drug interactions between auvelity and buprenorphine in participants with opioid use disorder who are receiving medication for OUD (MOUD) with buprenorphine.
Further research today and join our compensated study!
Study Background
Virginia Commonwealth University is looking for participants to study the interaction between buprenorphine and a depression medication for opioid use disorder.
Our study is to examine safety-tolerability and drug-drug interactions between auvelity and buprenorphine in participants with opioid use disorder who are receiving medication for OUD (MOUD) with buprenorphine.
Primary outcome measures:
- Safety: Heart rate (HR), blood pressure (BP), respiration (pulse oximetry, respiratory rate), adverse events.
- Buprenorphine PK: Plasma concentration-time profiles of buprenorphine and its metabolite norbuprenorphine
Further research today and join our compensated study!
Additional Information
You may qualify for this study if you meet the following criteria.
- Ages 18-65
- Currently in buprenorphine treatment for opioid use
- Willing and able to complete the study which could be spread out over the course of up to 84 days
Subjects will be on study for up to 84 days (including intervening weekends, and a 30 day washout period, if necessary)
